1650 Owens Street
102 articles with Gladstone Institutes
Nadia Roan, PhD, who first came to Gladstone Institutes as a postdoctoral scholar in 2007 and has been a visiting scientist since 2012, is now joining the biomedical research institution as an associate investigator.
The National Institutes of Health has granted an NIH Director's New Innovator Award to Seth Shipman, PhD, assistant investigator at Gladstone Institutes.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.
Researchers at San Francisco’s Gladstone Institutes published research on bioRxiv—which means it has not been peer-reviewed—that demonstrated, in culture, how the virus damages cardiac muscles.
While antibodies may fade fast, T cells appear to be long-lived and might confer lasting immunity
A person living with HIV can keep the virus in check by adhering to daily treatment with antiretroviral drugs.
HIV remodels its target cells, facilitating spread from the female reproductive tract to the rest of the body, shows a new study at Gladstone Institutes
Biotech Bay, the bustling biotech industry around San Francisco in California, is home to many biopharma companies developing diagnostics, therapies, and vaccines to fight against coronavirus disease 2019 (COVID-19) and the virus that causes it, called SARS-CoV-2.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
New study identifies a type of T cells in tissues that preferentially supports latent infection by HIV
Gladstone has identified key needs and priorities, including the President's Coronavirus Research Fund, to help labs pivot quickly.
In response to the COVID-19 pandemic, Gladstone scientists have rapidly pivoted the focus of their research labs to the novel virus, SARS-CoV-2.
New study shows reducing levels of the protein tau prevents core autism symptoms in animal models
The focus of the research will be to learn more about ApoE4 and how and why it affects Alzheimer’s disease.
Katherine Pollard becomes director of the Biological and Medical Informatics Graduate Program at UC San Francisco
$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease
NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
Gladstone Investigators and Xyphos Partner to Successfully Adapt CAR-T Immunotherapy to Target the HIV Latent Reservoir
Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.
The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego.
Keller’s work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine.
First sequence of the Komodo dragon genome reveals clues about its evolution.